Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
UBS AG is issuing $200,000 of Trigger Autocallable Contingent Yield Notes linked to CrowdStrike Holdings (CRWD) common stock, maturing 25 June 2027. The notes are unsubordinated, unsecured debt of UBS and will pay an 11.06% p.a. contingent coupon (quarterly) only when the underlying share price closes at or above the coupon barrier of $245.91 (50% of the $491.81 initial level) on the relevant observation date. If on any quarterly observation date before maturity the CRWD closing level is at or above the initial level, the notes are automatically called, returning principal plus the coupon for that period; no further payments are made.
If not called, repayment outcomes at maturity hinge on the downside threshold, also set at $245.91. A final level at or above the threshold returns full principal; a level below it triggers a loss matching CRWD’s percentage decline from the initial level, up to total loss. Principal protection is therefore only conditional.
The issue price is $10 per note, with a $0.15 underwriting discount; estimated initial value is $9.79, reflecting dealer margins and UBS funding costs. Minimum purchase is 100 notes ($1,000). The securities will not be listed, limiting secondary-market liquidity, and purchasers are exposed both to market risk in CRWD and UBS credit risk.
Key dates: trade 23 Jun 2025, settlement 25 Jun 2025 (T+2), quarterly observations, final valuation 23 Jun 2027, maturity 25 Jun 2027. CUSIP 90309J305 / ISIN US90309J3059.